Contract Manufacturers Arrotek, NeedleTech Pen Merger

The merger expands the companies service reach globally, particularly in the United States and European Union.

Katie Hobbins, Managing Editor

October 26, 2023

1 Min Read
Roman Didkivskyi / iStock via Getty Images

Medical device contract manufacturing companies Arrotek and NeedleTech recently announced they have merged under the Arrotek brand, extending manufacturing services and medical device design expertise globally, and particularly in the United States and European Union.

Arrotek specializes in the design, development, and manufacture of interventional and diagnostic catheters for companies around the world. The company works as a full-service design consultancy, offering services from the initial concept stages of product development to commercialization and manufacture of finished products.

NeedleTech is a contract manufacturing specializing in the medical device industry providing custom specialty needles, cannulas, stylets, and similar steel components. Its concept-to-commercialization capabilities include needle point grinding, CNC Swiss machining, metal forming and finishing, and overmolding. Its medical device engineering and design for manufacturing (DFM) services also include tool and fixture fabrication and rapid prototyping.

Both companies have strong records serving the medtech industry, with customers consisting of OEMs, medical device startups, and corporations.

The brands are part of the Theragenics group of companies and the merger will include two centers of excellence, with a facility in Massachusetts focusing on metal components and an Irish facility focusing on plastics.

Arrotek and NeedleTech stated, in the press release announcing the merger, that the new venture enables them to build on foundations of quality, flexibility, and industry-leading innovation while integrating existing skills, capabilities, and knowledge across both business units.

“I am delighted to announce the merger of our two current brands, Arrotek and NeedleTech,” said Mark Pugh, director of the OEM Group, Theragenics. “This merger will enhance our current offering, extending the services we provide. We are also investing in our shared engineering departments to put the structures in place to take our business forward.”

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like